EXACT Therapeutics publishes Annual Report 2023

Written By John M. Edminson
John M. Edminson
Previous

EXACT Therapeutics Company update: Full focus on Phase 2 pancreatic cancer trial
Next

EXACT Therapeutics presented poster at American Association for Cancer Research